en · de · es · fr · pt
cjc-1295-notes.peptides6823.com › Faq › Molecular Background And Naming — Reference Sheet

Molecular Background And Naming — Reference Sheet

By Editorial Desk · published 2025-12-13 · last reviewed 2026-01-23 · Faq

If you have been reading about albumin binding and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2026-01-23. Where a claim depends on a specific study, the study is described rather than over-claimed.

Molecular Background and Naming

The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.

CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.

Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.

Compound Identity and Development History

The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.

Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.

CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.

Cjc-1295 at a glance

PropertyValueNotes
Molecular weight (no linker)~3.37 kDaCalculated from peptide sequence
Molecular weight (with linker)~3.65 kDaIncludes albumin-binding moiety
AppearanceWhite to off-white powderTypically lyophilized
SolubilitySoluble in waterAlso dissolves in aqueous buffers
Common synonymsModified GRF(1-29), DAC:GRFUsage varies by source

Handling, Stability and Analysis

Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.

Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.

Related pages on this site

Identity and Naming History

The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.

Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.

CJC-1295 Structure And Mechanism

Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.

Persistence, Stability and Measurement

Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.

The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.

Supporting material

== Prognosis == Untreated hypersomatotropism has a guarded to poor prognosis. In most cases the insulin resistance and other symptoms get progressively worse causing insulin treatment to become difficult. Euthanasia often occurs a few months after diagnosis in cats due to owner's being unable or unwilling to deal with treatment. Other reasons for euthanasia include congestive heart failure, renal failure, respiratory distress, and neurological symptoms. Cats that have been treated with radiotherapy or pituitary surgery may have a good prognosis; survival has been observed for several years. In progestogen induced hypersomatotropism the prognosis is usually good after cessation of progestogen administration. In dogs soft tissue changes are usually resolved in a few weeks or months, persistent bone changes usually do not cause clinical problems. For diabetes mellitus the prognosis for the condition depends on the beta cell damage.

=== 1970s and 1980s === Hardee's purchased Sandy's in 1972. During the mid-and-late 1970s, Hardee's saw rapid chain growth and high profits on the strength of its two key sandwiches: the "Big Twin" and the "Big Deluxe". Another acquisition occurred in the late 1970s when Hardee's purchased the Utah-based burger chain Dee's Drive-In. In 1977; following a test run at a Virginia Beach location owned by longtime Hardee's franchise operator Boddie-Noell Enterprises, Hardee's introduced its breakfast menu and its Made from Scratch breakfast biscuits nationwide.

== Non-Christian stigmata == Among the Warao of the Orinoco Delta, a contemplator of tutelary spirits may mystically induce the development of "(imagined) openings in the palms of his hands". Bleeding wounds, described in Western sources as stigmata, are regularly indicated in Buddhist art. Some spiritualist mediums have also produced stigmata. During the séances of German medium Maria Vollhardt, it was alleged that bleeding wounds appeared. However, Albert Moll, a psychiatrist, considered her phenomena to be fraudulent.

Outer membrane proteins are membrane proteins with key roles associated with bacterial cell structure and morphology; cell membrane homeostasis; the uptake of nutrients; protection of the cell from toxins including antibiotics; and virulence factors including adhesins, exotoxins, and biofilm formation. There are a number of outer membrane proteins that are specifically virulence-related. Outer membrane proteins consist of two major classes of protein - transmembrane proteins and lipoproteins. The transmembrane proteins form channels or pores in the membrane called porins, and actively pumping efflux channels. The outer membranes of a bacterium can contain a huge number of proteins. In E. Coli for example there are around 500,000 in the membrane. Bacterial outer membrane proteins typically have a unique beta barrel structure that spans the membrane. The beta barrels fold to expose a hydrophobic surface before their insertion into the outer membrane. Beta barrels vary in sequence and size that ranges from 8 to 36 beta strands. A subset of OMPs have a perisplasmic or an extracellular link to their beta barrel structure. An outer membrane protein is translocated across the inner membrane through Sec machinery, and finally inserted to the outer membrane by the barrel assembly machinery complex.

Sources: en.wikipedia.org

Supporting material

== History == The first described attempts at producing weight loss are those of Soranus of Ephesus, a Greek physician, in the second century AD. He prescribed elixirs of laxatives and purgatives, as well as heat, massage, and exercise. This remained the mainstay of treatment for well over a thousand years. It was not until the 1920s and 1930s that new treatments began to appear. Based on its effectiveness for hypothyroidism, thyroid hormone became a popular treatment for obesity in euthyroid people. It had a modest effect but produced the symptoms of hyperthyroidism as a side effect, such as palpitations and difficulty sleeping. 2,4-Dinitrophenol (DNP) was introduced in 1933; this worked by uncoupling the biological process of oxidative phosphorylation in mitochondria, causing them to produce heat instead of ATP. Overdose caused fatal hyperthermia and DNP also caused cataracts in some users. After the passage of the Food, Drug, and Cosmetic Act in 1938, the FDA banned DNP for human consumption. Amphetamines (marketed as Benzedrine) became popular for weight loss during the late 1930s. They worked primarily by suppressing appetite, and had other beneficial effects such as increased alertness. Use of amphetamines increased over the subsequent decades, including Obetrol and culminating in the "rainbow diet pill" regime. This was a combination of multiple pills, all thought to help with weight loss, taken throughout the day.

== External links == The MEROPS online database for peptidases and their inhibitors: Stem Bromelain:C01.005[link removed], Fruit Bromelain:C01.028[link removed] Bromelains at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

== Cause == Burns are caused by a variety of external sources classified as thermal (heat-related), chemical, electrical, and radiation. In the United States, the most common causes of burns are: fire or flame (44%), scalds (33%), hot objects (9%), electricity (4%), and chemicals (3%). Most (69%) burn injuries occur at home or at work (9%), and most are accidental, with 2% due to assault by another, and 1–2% resulting from a suicide attempt. These sources can cause inhalation injury to the airway and/or lungs, occurring in about 6%. Burn injuries occur more commonly among the poor. Smoking and alcoholism are other risk factors. Fire-related burns are generally more common in colder climates. Specific risk factors in the developing world include cooking with open fires or on the floor as well as developmental disabilities in children and chronic diseases in adults.

=== Australia === A study by the Australian National University published in 2022 for Food Standards Australia New Zealand estimated there are 4.67 million cases of food poisoning in Australia each year that result in 47,900 hospitalisations, 38 deaths and a cost to the economy of $2.1 billion. A previous study using different methodology and published in November 2014, found in 2010 that there were an estimated 4.1 million cases of foodborne gastroenteritis acquired in Australia on average each year, along with 5,140 cases of non-gastrointestinal illness. The main causes were norovirus, pathogenic Escherichia coli, Campylobacter spp. and non-typhoidal Salmonella spp., although the causes of approximately 80% of illnesses were unknown. Approximately 25% (90% CrI: 13%–42%) of the 15.9 million episodes of gastroenteritis that occur in Australia were estimated to be transmitted by contaminated food. This equates to an average of approximately one episode of foodborne gastroenteritis every five years per person. Data on the number of hospitalisations and deaths represent the occurrence of serious foodborne illness. Including gastroenteritis, non-gastroenteritis and sequelae, there were an estimated annual 31,920 (90% CrI: 29,500–35,500) hospitalisations due to foodborne illness and 86 (90% CrI: 70–105) deaths due to foodborne illness circa 2010. This study concludes that these rates are similar to recent estimates in the US and Canada. A main aim of this study was to compare if foodborne illness incidence had increased over time.

To ensure highly anisotropic, yet predictable solidification behavior within the SSZ, dynamic freezing patterns are preferred. Using dynamic freezing, the velocity of the solidification front, and, therefore, the ice crystal size, can be controlled with a changing temperature gradient. The increasing thermal gradient counters the effect of the growing thermal buffer imposed by the growing ice front. It has been shown that a linearly decreasing temperature on one side of a freeze-cast will result in near-constant solidification velocity, yielding ice crystals with an almost constant thickness along the SSZ of an entire sample. However, as pointed out by Waschkies et al. even with constant solidification velocity, the thickness of the ice crystals does increase slightly over the course of freezing. In contrast to that, Flauder et al. demonstrated that an exponential change of the temperature at the cooling plate leads to a constant ice crystal thickness within the complete SSZ, which was attributed to a measurably constant ice-front velocity in a distinct study. This approach enables a prediction of the ice-front velocity from the thermal parameters of the suspension. Consequently, if the exact relationship between the pore diameter and ice-front velocity is known, an exact control over the pore diameter can be achieved.

Sources: en.wikipedia.org

Notes from published material

== Incumbents == Lord Lieutenant of Anglesey – Henry Paget Lord Lieutenant of Brecknockshire and Monmouthshire – Henry Somerset, 6th Duke of Beaufort Lord Lieutenant of Caernarvonshire – Thomas Bulkeley, 7th Viscount Bulkeley Lord Lieutenant of Cardiganshire – Thomas Johnes Lord Lieutenant of Carmarthenshire – George Rice, 3rd Baron Dynevor Lord Lieutenant of Denbighshire – Sir Watkin Williams-Wynn, 5th Baronet Lord Lieutenant of Flintshire – Robert Grosvenor, 1st Marquess of Westminster Lord Lieutenant of Glamorgan – John Stuart, 1st Marquess of Bute Lord Lieutenant of Merionethshire – Sir Watkin Williams-Wynn, 5th Baronet Lord Lieutenant of Montgomeryshire – Edward Clive, 1st Earl of Powis Lord Lieutenant of Pembrokeshire – Richard Philipps, 1st Baron Milford Lord Lieutenant of Radnorshire – George Rodney, 3rd Baron Rodney Bishop of Bangor – William Cleaver (until 25 November) Bishop of Llandaff – Richard Watson Bishop of St Asaph – Samuel Horsley (until 4 October); William Cleaver (from 25 November) Bishop of St Davids – Thomas Burgess

taxis A directional response by a cell or a population of cells to a specific stimulus; a movement or other activity occurring in a non-random direction and dependent on the direction from which the stimulus originated. This contrasts with kinesis, a response without directional bias.

Nanocarbon: From Graphene to Buckyballs. Interactive 3D models of cyclohexane, benzene, graphene, graphite, chiral & non-chiral nanotubes, and C60 Buckyballs – WeCanFigureThisOut.org. C60 and Carbon Nanotubes a short video explaining how nanotubes can be made from modified graphite sheets and the three different types of nanotubes that are formed Learning module for Bandstructure of Carbon Nanotubes and Nanoribbons Selection of free-download articles on carbon nanotubes WOLFRAM Demonstrations Project: Electronic Band Structure of a Single-Walled Carbon Nanotube by the Zone-Folding Method WOLFRAM Demonstrations Project: Electronic Structure of a Single-Walled Carbon Nanotube in Tight-Binding Wannier Representation

The human–animal bond can occur between people and domestic or wild animals; be it a cat as a pet or birds outside one's window. The phrase "Human-Animal Bond" or HAB began to emerge as terminology in the late 1970s and early 1980s. Research into the nature and merit of the human–animal bond began in the late 18th century when, in York, England, the Society of Friends established The Retreat to provide humane treatment for the mentally ill. By having patients care for the many farm animals on the estate, society officials theorized that the combination of animal contact plus productive work would facilitate the patients' rehabilitation. In the 1870s in Paris, a French surgeon had patients with neurological disorders ride horses. The patients were found to have improved their motor control and balance and were less likely to suffer bouts of depression. During the 1820s to 1870s, America's Victorian middle class used the human–animal bond to aid in children's socialization. This was an entirely gendered process, as parents and society believed only boys had an innate tendency towards violence and needed to be socialized towards kindness and empathy through companion animals. Over time pet-keeping to socialize children became more gender neutral, but even into the 1980s and 90s there remained a belief that boys especially benefited from pet-keeping due to the fact that it was one of only ways they could practice nurturing given the limiting gender norms. An example of the human–animal bond can be seen during World War I on the Western Front with horses.

Sources: en.wikipedia.org

Frequently asked questions

Is CJC-1295 a natural hormone?

No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.

Why do two versions share one name?

Early development used the albumin-binding form, and a shorter variant was later discussed under the same label. Because the two differ in half-life and handling, ambiguity arises whenever a source omits the variant designation.

What is the relationship to GRF(1-29)?

The compound derives from that fragment but is not identical to it. The parent fragment lacks the stabilizing substitutions, so its degradation rate and duration of action differ noticeably.

What is CJC-1295?

It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.

Network